Breast implant capsule: A murine model comparing capsular contracture susceptibility among six breast implants available in the market

Background Breast implant capsule development and behavior are mainly determined by implant surface combined with other external factors such as intraoperative contamination, radiation or concomitant pharmacologic treatment. Thus, there are several diseases: capsular contracture, breast implant illn...

Descripción completa

Detalles Bibliográficos
Autores: Bérniz-Laborda, C.P. (C. P.)|||/items/aa37a2c6-8c10-4afa-9e90-12de5634a540, Carmona-Torre, F. (Francisco de A.)|||/items/b76f0374-ce41-442e-8323-f9c9052a1bd4, Gómez-Martínez de Lecea, C. (Cristina)|||/items/09aca6c8-dae2-497a-abfb-ba60b6111647, Fernández-Ciriza, L. (Leire)|||/items/04f843e5-e2a5-4495-92a5-a04d0c887b56, Pozo-León, J.L. (José Luis) del|||/items/57998d0a-acfc-4fca-81d6-0a140da7b5b8, Hontanilla-Calatayud, B.C. (Bernardo Carlos)|||/items/95c47b38-25c5-4b1c-b165-68e3bfffce3a
Tipo de recurso: artículo
Fecha de publicación:2023
País:España
Institución:Universidad de Navarra
Repositorio:Dadun. Depósito Académico Digital de la Universidad de Navarra
Idioma:inglés
OAI Identifier:oai:dadun.unav.edu:10171/68795
Acceso en línea:https://hdl.handle.net/10171/68795
Access Level:acceso abierto
Palabra clave:Breast implant
Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)
Murine Mode
Capsular Contracture Susceptibility
Materias Investigacion::Ciencias de la Salud::Cirugía
Enfermedades infecciosas
id ES_8f26a96d97d4df705d3cda25d3a3b6de
oai_identifier_str oai:dadun.unav.edu:10171/68795
network_acronym_str ES
network_name_str España
repository_id_str
dc.title.none.fl_str_mv Breast implant capsule: A murine model comparing capsular contracture susceptibility among six breast implants available in the market
title Breast implant capsule: A murine model comparing capsular contracture susceptibility among six breast implants available in the market
spellingShingle Breast implant capsule: A murine model comparing capsular contracture susceptibility among six breast implants available in the market
Bérniz-Laborda, C.P. (C. P.)|||/items/aa37a2c6-8c10-4afa-9e90-12de5634a540
Breast implant
Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)
Murine Mode
Capsular Contracture Susceptibility
Materias Investigacion::Ciencias de la Salud::Cirugía
Enfermedades infecciosas
title_short Breast implant capsule: A murine model comparing capsular contracture susceptibility among six breast implants available in the market
title_full Breast implant capsule: A murine model comparing capsular contracture susceptibility among six breast implants available in the market
title_fullStr Breast implant capsule: A murine model comparing capsular contracture susceptibility among six breast implants available in the market
title_full_unstemmed Breast implant capsule: A murine model comparing capsular contracture susceptibility among six breast implants available in the market
title_sort Breast implant capsule: A murine model comparing capsular contracture susceptibility among six breast implants available in the market
dc.creator.none.fl_str_mv Bérniz-Laborda, C.P. (C. P.)|||/items/aa37a2c6-8c10-4afa-9e90-12de5634a540
Carmona-Torre, F. (Francisco de A.)|||/items/b76f0374-ce41-442e-8323-f9c9052a1bd4
Gómez-Martínez de Lecea, C. (Cristina)|||/items/09aca6c8-dae2-497a-abfb-ba60b6111647
Fernández-Ciriza, L. (Leire)|||/items/04f843e5-e2a5-4495-92a5-a04d0c887b56
Pozo-León, J.L. (José Luis) del|||/items/57998d0a-acfc-4fca-81d6-0a140da7b5b8
Hontanilla-Calatayud, B.C. (Bernardo Carlos)|||/items/95c47b38-25c5-4b1c-b165-68e3bfffce3a
author Bérniz-Laborda, C.P. (C. P.)|||/items/aa37a2c6-8c10-4afa-9e90-12de5634a540
author_facet Bérniz-Laborda, C.P. (C. P.)|||/items/aa37a2c6-8c10-4afa-9e90-12de5634a540
Carmona-Torre, F. (Francisco de A.)|||/items/b76f0374-ce41-442e-8323-f9c9052a1bd4
Gómez-Martínez de Lecea, C. (Cristina)|||/items/09aca6c8-dae2-497a-abfb-ba60b6111647
Fernández-Ciriza, L. (Leire)|||/items/04f843e5-e2a5-4495-92a5-a04d0c887b56
Pozo-León, J.L. (José Luis) del|||/items/57998d0a-acfc-4fca-81d6-0a140da7b5b8
Hontanilla-Calatayud, B.C. (Bernardo Carlos)|||/items/95c47b38-25c5-4b1c-b165-68e3bfffce3a
author_role author
author2 Carmona-Torre, F. (Francisco de A.)|||/items/b76f0374-ce41-442e-8323-f9c9052a1bd4
Gómez-Martínez de Lecea, C. (Cristina)|||/items/09aca6c8-dae2-497a-abfb-ba60b6111647
Fernández-Ciriza, L. (Leire)|||/items/04f843e5-e2a5-4495-92a5-a04d0c887b56
Pozo-León, J.L. (José Luis) del|||/items/57998d0a-acfc-4fca-81d6-0a140da7b5b8
Hontanilla-Calatayud, B.C. (Bernardo Carlos)|||/items/95c47b38-25c5-4b1c-b165-68e3bfffce3a
author2_role author
author
author
author
author
dc.contributor.none.fl_str_mv Dadun. Depósito Académico Digital Universidad de Navarra
dc.subject.none.fl_str_mv Breast implant
Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)
Murine Mode
Capsular Contracture Susceptibility
Materias Investigacion::Ciencias de la Salud::Cirugía
Enfermedades infecciosas
topic Breast implant
Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)
Murine Mode
Capsular Contracture Susceptibility
Materias Investigacion::Ciencias de la Salud::Cirugía
Enfermedades infecciosas
description Background Breast implant capsule development and behavior are mainly determined by implant surface combined with other external factors such as intraoperative contamination, radiation or concomitant pharmacologic treatment. Thus, there are several diseases: capsular contracture, breast implant illness or Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL), that have been correlated with the specific type of implant placed. This is the first study to compare all major implant and texture models available in the market on the development and behave of the capsules. Through a histopathological analysis, we compared the behavior of different implant surfaces and how different cellular and histological properties give rise to different susceptibilities to develop capsular contracture among these devices. Methods A total of 48 Wistar female rats were used to implant 6 different types of breast implants. Mentor®, McGhan®, Polytech polyurethane®, Xtralane®, Motiva® and Natrelle Smooth® implants were employed; 20 rats received Motiva®, Xtralane® and Polytech polyurethane®, and 28 rats received Mentor®, McGhan® and Natrelle Smooth® implants. The capsules were removed five weeks after the implants placement. Further histological analysis compared capsule composition, collagen density and cellularity. Results High texturization implants showed the highest levels of collagen and cellularity along the capsule. However, polyurethane implants capsules behaved differently regarding capsule composition, with the thickest capsules but fewer collagen and myofibroblasts than expected, despite being generally considered as a macrotexturized implant. Nanotextured implants and microtextured implants histological findings showed similar characteristics and less susceptibility to develop a capsular contracture compared with smooth implants. Conclusions This study shows the relevance of the breast implant surface on the definitive capsules’ development, since this is one of the most differentiated factors that determine the incidence of capsular contracture and probably other diseases like BIA-ALCL. A correlation of these findings with clinical cases will help to unify implant classification criteria based on their shell and their estimated incidence of capsule-associated pathologies. Up to this point, the establishment of additional groups is recommended as nanotexturized implants seem to behave differently to pure smooth surfaces and polyurethane implants present diverse features from macro- or microtextured implants. No Level Assigned This journal requires that authors assign a level of evidence to each submission to which Evidence-Based Medicine rankings are applicable. This excludes Review Articles, Book Reviews, and manuscripts that concern Basic Science, Animal Studies, Cadaver Studies, and Experimental Studies. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors
publishDate 2023
dc.date.none.fl_str_mv 2023
2023-01-01
2023
2023-01-01
2024
2024-02-05
dc.type.none.fl_str_mv journal article
http://purl.org/coar/resource_type/c_6501
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv https://hdl.handle.net/10171/68795
url https://hdl.handle.net/10171/68795
dc.language.none.fl_str_mv Inglés
eng
language_invalid_str_mv Inglés
language eng
dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Springer
publisher.none.fl_str_mv Springer
dc.source.none.fl_str_mv reponame:Dadun. Depósito Académico Digital de la Universidad de Navarra
instname:Universidad de Navarra
instname_str Universidad de Navarra
reponame_str Dadun. Depósito Académico Digital de la Universidad de Navarra
collection Dadun. Depósito Académico Digital de la Universidad de Navarra
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869413187706683393
spelling Breast implant capsule: A murine model comparing capsular contracture susceptibility among six breast implants available in the marketBérniz-Laborda, C.P. (C. P.)|||/items/aa37a2c6-8c10-4afa-9e90-12de5634a540Carmona-Torre, F. (Francisco de A.)|||/items/b76f0374-ce41-442e-8323-f9c9052a1bd4Gómez-Martínez de Lecea, C. (Cristina)|||/items/09aca6c8-dae2-497a-abfb-ba60b6111647Fernández-Ciriza, L. (Leire)|||/items/04f843e5-e2a5-4495-92a5-a04d0c887b56Pozo-León, J.L. (José Luis) del|||/items/57998d0a-acfc-4fca-81d6-0a140da7b5b8Hontanilla-Calatayud, B.C. (Bernardo Carlos)|||/items/95c47b38-25c5-4b1c-b165-68e3bfffce3aBreast implantBreast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)Murine ModeCapsular Contracture SusceptibilityMaterias Investigacion::Ciencias de la Salud::CirugíaEnfermedades infecciosasBackground Breast implant capsule development and behavior are mainly determined by implant surface combined with other external factors such as intraoperative contamination, radiation or concomitant pharmacologic treatment. Thus, there are several diseases: capsular contracture, breast implant illness or Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL), that have been correlated with the specific type of implant placed. This is the first study to compare all major implant and texture models available in the market on the development and behave of the capsules. Through a histopathological analysis, we compared the behavior of different implant surfaces and how different cellular and histological properties give rise to different susceptibilities to develop capsular contracture among these devices. Methods A total of 48 Wistar female rats were used to implant 6 different types of breast implants. Mentor®, McGhan®, Polytech polyurethane®, Xtralane®, Motiva® and Natrelle Smooth® implants were employed; 20 rats received Motiva®, Xtralane® and Polytech polyurethane®, and 28 rats received Mentor®, McGhan® and Natrelle Smooth® implants. The capsules were removed five weeks after the implants placement. Further histological analysis compared capsule composition, collagen density and cellularity. Results High texturization implants showed the highest levels of collagen and cellularity along the capsule. However, polyurethane implants capsules behaved differently regarding capsule composition, with the thickest capsules but fewer collagen and myofibroblasts than expected, despite being generally considered as a macrotexturized implant. Nanotextured implants and microtextured implants histological findings showed similar characteristics and less susceptibility to develop a capsular contracture compared with smooth implants. Conclusions This study shows the relevance of the breast implant surface on the definitive capsules’ development, since this is one of the most differentiated factors that determine the incidence of capsular contracture and probably other diseases like BIA-ALCL. A correlation of these findings with clinical cases will help to unify implant classification criteria based on their shell and their estimated incidence of capsule-associated pathologies. Up to this point, the establishment of additional groups is recommended as nanotexturized implants seem to behave differently to pure smooth surfaces and polyurethane implants present diverse features from macro- or microtextured implants. No Level Assigned This journal requires that authors assign a level of evidence to each submission to which Evidence-Based Medicine rankings are applicable. This excludes Review Articles, Book Reviews, and manuscripts that concern Basic Science, Animal Studies, Cadaver Studies, and Experimental Studies. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to AuthorsSpringerDadun. Depósito Académico Digital Universidad de Navarra20242024-02-0520232023-01-0120232023-01-01journal articlehttp://purl.org/coar/resource_type/c_6501info:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/10171/68795reponame:Dadun. Depósito Académico Digital de la Universidad de Navarrainstname:Universidad de NavarraInglésengopen accesshttp://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccessoai:dadun.unav.edu:10171/687952026-06-21T12:47:57Z
score 15,301603